RRR schreef op 20 augustus 2014 11:09:
[...]
Joseph Pantginis, Ph.D. joined ROTH Capital Partners in 2009. Prior to joining Roth Dr. Pantginis was a senior biotech analyst at Merriman Curhan Ford. Dr. Pantginis was also a senior biotechnology analyst at Canaccord Adams, focusing on the oncology, inflammation and infectious disease spaces. Prior to Canaccord Adams he was a biotech analyst at several firms, including JBHanauer & Co., First Albany Corporation, Commerce Capital Markets and Ladenburg Thalmann & Co., Inc. Prior to his tenure on Wall Street, Dr. Pantginis served as an associate manager/scientist of Regeneron Pharmaceuticals' Retrovirus Core Facility. Dr. Pantginis received an M.B.A. in Finance from Pace University; a Ph.D. in Molecular Genetics and an M.S. from Albert Einstein College of Medicine; and a B.S. from Fordham University.
Lijkt mij dat ie wel weet wat hij schrijft...
Maar ben het met je eens... Tis kiezen tussen hem en.... Al die goeroes hier...lastige keuze!!
El negro caballero bv... Jaaarenlange ervaring... Niet onderschatten die kerel... :-)